Showing Results for
- Academic Journals (304)
- 1From:Urologic Oncology: Seminars and Original Investigations (Vol. 41, Issue 5) Peer-Reviewed
Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis.Abstract Only
- 2From:BJU International (Vol. 131, Issue 5) Peer-Reviewed
Synchronous vs independent reading of prostate-specific membrane antigen positron emission tomography (PSMA-PET) and magnetic resonance imaging (MRI) to improve diagnosis of prostate cancer.Abstract Only
- 3From:Cancers (Vol. 15, Issue 6) Peer-ReviewedEpigenetic changes occur in parts of the genome other than in nucleotides. They are considered reversible and are therefore important targets for cancer therapy. Epigenetic changes have been observed in urological...
- 4From:Prostate International (Vol. 11, Issue 1) Peer-Reviewed
Robotic-assisted radical prostatectomy: learning curves and outcomes from an Australian perspective.Abstract Only
- 5From:ANZ Journal of Surgery (Vol. 93, Issue 3) Peer-Reviewed
Same day discharge for robot-assisted radical prostatectomy: a prospective cohort study documenting an Australian approach.Abstract Only
- 6From:Clinical Genitourinary Cancer (Vol. 21, Issue 1) Peer-ReviewedAbstract Only
- 8From:Current Opinion in Urology (Vol. 33, Issue 1) Peer-ReviewedAbstract Only
- 9From:BJU International (Vol. 131, Issue 1) Peer-Reviewed
Case of the Month from Peter MacCallum Cancer Centre, Melbourne, Australia: ICG-assisted robotic Boari flap ureteric reimplantation in a case of missed ureteric injury.Abstract Only
- 10From:BJU International (Vol. 131, Issue 1) Peer-ReviewedAbstract Only
- 11From:Cancers (Vol. 14, Issue 24) Peer-Reviewed
Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer—A Prospective Cohort Study.PSMA PET-CT is a new scan which has now been proven to be the most accurate in detecting prostate cancer outside the prostate gland. It is now recommended by international guidelines to be used before treatment is...
- 12From:BJU International (Vol. 130, Issue 6) Peer-ReviewedAbstract Only
- 13From:Current Opinion in Supportive and Palliative Care (Vol. 16, Issue 4) Peer-ReviewedAbstract Only
- 14From:BJU International (Vol. 130, Issue 5) Peer-Reviewed
Active surveillance versus enzalutamide for low-risk prostate cancer - was it really a trial we needed?Abstract Only
- 15From:BJU International (Vol. 130, Issue S3) Peer-Reviewed
Prostate-specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer.Abstract Only
- 16From:BJU International (Vol. 130, Issue S3) Peer-Reviewed
Funding of all issues related to prostate cancer treatment should be a priority and have equal access - a key to survivorship.Abstract Only
- 17From:Cancer Imaging (Vol. 22, Issue 1) Peer-ReviewedBackground Survivors of testicular cancer may experience long-term morbidity following treatment. There is an unmet need to investigate techniques that can differentiate individuals who need additional therapy from...
- 18From:Prostate International (Vol. 10, Issue 3) Peer-ReviewedAbstract Only
- 19From:ANZ Journal of Surgery (Vol. 92, Issue 9) Peer-ReviewedAbstract Only
- 20From:Current Opinion in Urology (Vol. 32, Issue 5) Peer-ReviewedAbstract Only
Choose how you want to be alerted when new results for your search become available.
Subscribe to Gale's RSS feed to get content delivered to your favorite RSS aggregator. Copy and paste the URL below into your reader:
Tell us where to send the alert and how often you want to receive it